On the surface, a gathering held for young research faculty last week at Cold Spring Harbor Laboratory was a clear expression of determination by the National Institutes of Health (NIH) to help them compete for grants. The agency fears that continued Congressional budget cuts, combined with the growing number of scientists who work later into…

The evolution from classical genetics to biotechnology, an area of research involving key macromolecules in living cells, is chronicled and the current state of biotechnology is described, noting related advances in computing and clinical medicine. (MSE)

The House Interstate and Foreign Commerce Committee's regulatory legislation on recombinant DNA technology is discussed along with university reactions to it. Violations of federal guidelines and legal efforts are described. (LBH)

Highlights the background, career, and major accomplishments of Robert Allan Weinberg, professor of Biology at the Massachusetts Institute of Technology. His accomplishments and research interests focus on oncogenes, genes capable of causing cancer. The discovery of these genes has revealed the central mechanism of cancer. (Author/JN)

Government regulation of recombinant DNA research is addressed. Issues discussed include the potential of such research; National Institutes of Health guidelines; federal, state, and local regulation; the controversy over self-regulation; first amendment protection for scientific research; and problems in drafting legislation. (JMD)

Two conference presentations are summarized: (1) the Human Genome Project and other genetic discoveries and technologies, that offer improvements in diagnosis, disease prevention, and treatment, and that change the relationship between the academic medical center (AMC) and the pharmaceutical industry; and (2) new emphases on health-care outcomes…